PFSA

Profusa, Inc.

2.61 USD

Last updated Sep 12, 04:29 UTC

Yesterday HIGH

$2.65

Yesterday LOW

$2.37

52w HIGH

$4,500.01

52w LOW

$2.37

EPS

-151.80

PE

-0.02

Next Earnings

Nov 18, 2026

Overview News Insider Transactions Government Trades Fundamentals

Profusa, Inc. stock is down -31.45% since 30 days ago. The next earnings date is Nov 18, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 September’s closed higher than August.

Webmaster

Fri Aug 14, 2026

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk

Thu Aug 13, 2026

Profusa shares are trading lower after the company announced a 1-for-4 reverse stock split.
Benzinga Newsdesk

Thu Aug 13, 2026

Profusa Announces 1-For-4 Reverse Stock Split Effective August 17
Benzinga Newsdesk

Mon Aug 3, 2026

Profusa shares are trading lower after the company obtained the right and option, but not the obligation, to buy diagnostics firm G3 Vision Labs.
Benzinga Insights

Fri Jul 31, 2026

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's after-market session. The company's market cap stands at $2.2 million. BGM Group (NASDAQ:BGM) stock rose 11.63%
Benzinga Newsdesk

Fri Jul 31, 2026

Profusa Enters Option Agreement To Buy G3 Vision Labs And Affiliates; Has Right To Buy 100% Of G3 Vision Labs

-SEC Filing
Benzinga Insights

Mon Jul 27, 2026

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular session. The company's market cap stands at $100.9 million. Gossamer Bio (NASDAQ:GOSS) shares moved upwards by
Benzinga Newsdesk

Mon Jul 27, 2026

Profusa shares are trading lower after the company announced the signing of a non-binding term sheet with a privately held, commercial-stage health diagnostics and toxicology testing company.
Benzinga Insights

Mon Jul 27, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Matinas BioPharma Hldgs (AMEX:MTNB) shares increased by 59.7% to $0.39 during Monday's pre-market session. The company's market cap stands at $1.5 million. Forte Biosciences (NASDAQ:FBRX) stock rose
Akanksha Bakshi

Mon Jul 27, 2026

Why Is Profusa Stock Falling Monday?

PFSA stock fell 18.5% in premarket trading after Profusa named a new CEO and signed a deal to acquire a $111M diagnostics firm.

Fred Knechtel, Chief Financial Officer

Fri Aug 21, 2026

PFSA Recent Insider Trades and Stock Chart

301,991 shares other
Fred Knechtel, Chief Financial Officer

Fri Aug 21, 2026

PFSA Recent Insider Trades and Stock Chart

54,323 shares other
Jack Stover, Chief Executive Officer

Fri Aug 21, 2026

PFSA Recent Insider Trades and Stock Chart

301,991 shares other
Jack Stover, Chief Executive Officer

Fri Aug 21, 2026

PFSA Recent Insider Trades and Stock Chart

32,018 shares other
HRT FINANCIAL LP, 10% Owner

Wed Aug 12, 2026

PFSA Recent Insider Trades and Stock Chart

5,585 shares bought
HRT FINANCIAL LP, 10% Owner

Mon Aug 17, 2026

PFSA Recent Insider Trades and Stock Chart

18,395 shares sold
HRT FINANCIAL LP, 10% Owner

Fri Aug 14, 2026

PFSA Recent Insider Trades and Stock Chart

3,163 shares sold
HRT FINANCIAL LP, 10% Owner

Thu Aug 13, 2026

PFSA Recent Insider Trades and Stock Chart

42,411 shares sold
HRT FINANCIAL LP, 10% Owner

Tue Aug 11, 2026

PFSA Recent Insider Trades and Stock Chart

2,280 shares sold
HRT FINANCIAL LP, 10% Owner

Mon Aug 10, 2026

PFSA Recent Insider Trades and Stock Chart

4,016 shares bought